DNA methyltransferase 3B (DNMT3B) in multiple myeloma: a pivotal role in myeloma cell survival, drug resistance and disease progression? Vrije Universiteit Brussel
Multiple myeloma (MM) is a rarely curable disease characterised by the accumulation of malignant plasma cells in the bone marrow. Although most MM patients initially respond well to the current therapies, there is a high chance of relapse after every round of treatment due to the development of drug resistance (DR).
This urges researchers to discover new targets to counter this DR. Next to genetic defects, it is now widely recognized that ...
This urges researchers to discover new targets to counter this DR. Next to genetic defects, it is now widely recognized that ...